Fleury SA
BOVESPA:FLRY3

Watchlist Manager
Fleury SA Logo
Fleury SA
BOVESPA:FLRY3
Watchlist
Price: 16.32 BRL -1.09%
Market Cap: R$8.9B

EV/OCF

5.4
Current
7%
Cheaper
vs 3-y average of 5.8

Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.

EV/OCF
5.4
=
Enterprise Value
R$11.2B
/
Operating Cash Flow
R$2.1B

Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.

EV/OCF
5.4
=
Enterprise Value
R$11.2B
/
Operating Cash Flow
R$2.1B

Valuation Scenarios

Fleury SA is trading below its 3-year average

If EV/OCF returns to its 3-Year Average (5.8), the stock would be worth R$17.52 (7% upside from current price).

Statistics
Positive Scenarios
3/4
Maximum Downside
-7%
Maximum Upside
+65%
Average Upside
26%
Scenario EV/OCF Value Implied Price Upside/Downside
Current Multiple 5.4 R$16.32
0%
3-Year Average 5.8 R$17.52
+7%
5-Year Average 7.3 R$22.33
+37%
Industry Average 5 R$15.1
-7%
Country Average 8.9 R$26.99
+65%

Forward EV/OCF
Today’s price vs future operating cash flow

Not enough data available to calculate forward EV/OCF

Peer Comparison

All Multiples
EV/OCF
P/E
All Countries
Close
Market Cap EV/OCF P/E
BR
Fleury SA
BOVESPA:FLRY3
8.9B BRL 5.4 14.5
US
CVS Health Corp
NYSE:CVS
100.2B USD 14.1 56.7
US
Cigna Group
XMUN:CGN
68.5B EUR 10.5 13.2
US
Cigna Corp
NYSE:CI
73.7B USD 0 12.4
DE
Fresenius Medical Care AG
XMUN:FME
23.1B EUR 11.1 23.6
DE
Fresenius SE & Co KGaA
XETRA:FRE
22.9B EUR 12.2 17.9
US
Quest Diagnostics Inc
NYSE:DGX
22.1B USD 14.5 21.7
US
Laboratory Corporation of America Holdings
NYSE:LH
21.8B USD 16 24.8
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
10.9B EUR 6.5 11.1
US
Guardant Health Inc
NASDAQ:GH
11.5B USD -64.9 -27.6
US
DaVita Inc
NYSE:DVA
10.6B USD 10.5 14.2

Market Distribution

Lower than 73% of companies in Brazil
Percentile
27th
Based on 434 companies
27th percentile
5.4
Low
0.2 — 5.8
Typical Range
5.8 — 12.8
High
12.8 —
Distribution Statistics
Brazil
Min 0.2
30th Percentile 5.8
Median 8.9
70th Percentile 12.8
Max 3 401.7

Fleury SA
Glance View

Market Cap
8.9B BRL
Industry
Health Care

Fleury SA, originally founded in 1926, stands as a paragon of healthcare excellence in Brazil, evolving over nearly a century into a leading provider of medical diagnostics and integrated healthcare services. Driven by a culture of innovation and customer commitment, the company operates a network of strategically located diagnostic centers, offering a comprehensive array of tests, from basic blood work to sophisticated imaging. At the core of Fleury's operations is their ability to seamlessly blend cutting-edge technology with medical expertise, enabling them to deliver accurate diagnostics and personalized healthcare solutions. This approach not only enhances patient experiences but also fortifies their position in a highly competitive marketplace. In generating revenue, Fleury SA capitalizes on its robust infrastructure and premium service quality. The company’s business model thrives on a vast portfolio of diagnostic services, catering to an array of clientele — from individuals seeking routine checks to physicians requiring specialized analyses. Additionally, Fleury extends its reach through partnerships with hospitals and clinics, further solidifying its reputation and reliability. By maintaining a focus on operational efficiency and strategic expansions, the company ensures steady cash flows, which in turn are reinvested into technological advancements and service enhancements. This, coupled with their focus on high-quality client relations, fuels Fleury’s ability to retain a loyal customer base and sustain its financial growth trajectory.

FLRY3 Intrinsic Value
16.44 BRL
Undervaluation 1%
Intrinsic Value
Price R$16.32
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett